⌘K

Login Start Free

Home/Filings/4/0000950156-13-000020

4//SEC Filing

Hemric Michael B. 4

Accession 0000950156-13-000020

CIK 0000352998other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 5:04 PM ET

Size

17.8 KB

Accession

0000950156-13-000020

Insider Transaction Report

Form 4

Period: 2013-01-02

IGI LABORATORIES, INCIG

Hemric Michael B.

Director

Transactions

Purchase
Common Stock
2013-03-12$1.34/sh+2,100$2,814→ 23,522 total
Purchase
Common Stock
2013-03-06$1.14/sh+4,998$5,698→ 7,883 total
Purchase
Common Stock
2013-03-08$1.18/sh+1,532$1,808→ 17,054 total
Purchase
Common Stock
2013-03-11$1.18/sh+468$552→ 17,522 total
Purchase
Common Stock
2013-03-11$1.21/sh+3,000$3,630→ 20,522 total
Purchase
Common Stock
2013-03-07$1.15/sh+7,639$8,785→ 15,522 total
Purchase
Common Stock
2013-03-12$1.33/sh+900$1,202→ 21,422 total
Award
Stock Option
2013-01-02+10,000→ 10,000 total
Exercise: $1.04From: 2014-01-02Exp: 2023-01-02→ Common Stock (10,000 underlying)
Award
Stock Option
2013-01-02+15,000→ 15,000 total
Exercise: $1.04From: 2014-01-02Exp: 2023-01-02→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]These securities were granted as part of the Issuer's annual equity compensation to its non-employee directors under the Issuer's 1999 Director Stock Option Plan.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IGI LABORATORIES, INC

CIK 0000352998

Entity typeother

Related Parties

1

filerCIK 0001467550

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 5:04 PM ET
Size: 17.8 KB

View on SEC.gov